# Marpai, Inc. (MRAI)

> Cited company facts from SEC filings, by Steadybase. Web page: https://steadybase.io/company/marpai-inc/ JSON: https://steadybase.io/company/marpai-inc.json Checked Nov 10, 2026. Latest filing read: Oct 23, 2026.

## Company

- Legal name: Marpai, Inc.
- Ticker: MRAI (OTC)
- SEC CIK: 0001844392
- Industry: Services-Misc Health & Allied Services, NEC (SIC 8090)
- Headquarters: Tampa, FL
- Fiscal year ends: December 31
- SEC filer category: Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
- Website: marpaihealth.com
- Investor relations: https://ir.marpaihealth.com
- LinkedIn: https://www.linkedin.com/company/marpaihealth
- Next earnings date: Nov 13, 2026 (estimated from past 8-K timing)

## Key facts

- Revenue: $18.1M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 25, 2026). Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026034129/0001213900-26-034129-index.html
- Operating income: -$13.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 25, 2026). Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026034129/0001213900-26-034129-index.html
- Net income: -$16.6M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 25, 2026). Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026034129/0001213900-26-034129-index.html
- SG&A: $12.2M for the fiscal year ended Dec 31, 2025 (10-K filed Mar 25, 2026). Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026034129/0001213900-26-034129-index.html
- Employees: 107 as of , as reported in an SEC filing. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026034129/ea0282918-10k_marpai.htm
- Shares outstanding: 26,829,834 as of Aug 13, 2026 (10-Q filed Aug 13, 2026). Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026089120/0001213900-26-089120-index.html
- Auditor: Uhy LLP, Melville, New York, named in the latest 10-K. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026034129/ea0282918-10k_marpai.htm

## Business

We are a technology platform company which operates subsidiaries that provide Third Party Administrator (“TPA”), Pharmacy Benefit Management (“PBM”), and value-oriented health plan services to employers that directly pay for employee health benefits.

Source: Item 1. Business, https://www.sec.gov/Archives/edgar/data/1844392/000121390026034129/ea0282918-10k_marpai.htm

## Annual results

| Fiscal year ended | Revenue | Operating income | Net income | SG&A |
|---|---|---|---|---|
| Dec 31, 2025 | $18.1M | -$13.6M | -$16.6M | $12.2M |
| Dec 31, 2024 | $28.2M | -$22.1M | -$22.1M | $14.6M |
| Dec 31, 2023 | $37.2M | -$28.0M | -$28.8M | $25.8M |
| Dec 31, 2022 | $24.3M | -$27.0M | -$26.5M | $19.3M |
| Dec 31, 2021 | $14.2M | -$15.9M | -$16.0M | $13.0M |

Each figure comes from the annual report for that year. Filing links for every figure: https://steadybase.io/company/marpai-inc.json

## Officers and directors

- Damien Lamendola, Chief Executive Officer. Source: Form 4 filed Jun 2, 2026, https://www.sec.gov/Archives/edgar/data/1844392/000121390026064244/0001213900-26-064244-index.htm
- Steve Andrew Johnson, Chief Financial Officer. Source: Form 4 filed Jun 2, 2026, https://www.sec.gov/Archives/edgar/data/1844392/000121390026064257/0001213900-26-064257-index.htm
- Dallas Scrip, Chief Operating Officer. Source: Form 4 filed Nov 12, 2025, https://www.sec.gov/Archives/edgar/data/1844392/000121390025108614/0001213900-25-108614-index.htm

## Recent 8-K events

- Jul 31, 2026: Item 1.01, Entry into a material definitive agreement; Item 3.02, Unregistered sales of equity securities; Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026084129/ea0300139-8k_marpai.htm
- Jul 20, 2026: Item 1.01, Entry into a material definitive agreement; Item 8.01, Other events; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026079599/ea0298569-8k_marpai.htm
- May 1, 2026: Item 1.01, Entry into a material definitive agreement; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026050958/ea0288665-8k_marpai.htm
- Mar 11, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026025966/ea0280979-8k_marpai.htm
- Feb 13, 2026: Item 1.01, Entry into a material definitive agreement; Item 2.03, Creation of a direct financial obligation; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026016406/ea0277061-8k_marpai.htm
- Jan 23, 2026: Item 5.02, Departure or appointment of directors or officers; compensation. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026007191/ea027392101-8k_marpai.htm
- Dec 23, 2025: Item 1.01, Entry into a material definitive agreement; Item 3.02, Unregistered sales of equity securities; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025124729/ea0270704-8k_marpai.htm
- Nov 12, 2025: Item 2.02, Results of operations and financial condition (earnings release); Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025109369/ea0265410-8k_marpai.htm
- Nov 12, 2025: Item 1.01, Entry into a material definitive agreement; Item 3.02, Unregistered sales of equity securities; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025108593/ea0264918-8k_marpai.htm
- Oct 20, 2025: Item 5.03, Amendments to articles or bylaws; change in fiscal year; Item 9.01, Financial statements and exhibits. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025100355/ea0261663-8k_marpai.htm

## Insider trades (Form 4)

- Jun 2, 2026: Steve Andrew Johnson (Chief Financial Officer) bought 1,100 shares, about $682. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026064257/0001213900-26-064257-index.htm
- May 20, 2026: Yaron Eitan (Director) bought 10,000 shares, about $2,700. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390026060552/0001213900-26-060552-index.htm
- Nov 7, 2025: Yaron Eitan (Director) bought 100,000 shares, about $100,000. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025108618/0001213900-25-108618-index.htm
- Nov 7, 2025: Sagiv Shiv (Director) bought 50,000 shares, about $50,000. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025108615/0001213900-25-108615-index.htm
- Nov 7, 2025: Robert M. Pons (Director) bought 50,000 shares, about $50,000. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025108613/0001213900-25-108613-index.htm
- Sep 30, 2025: Damien Lamendola (Chief Executive Officer) bought 147,058 shares, about $199,999. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025095500/0001213900-25-095500-index.htm
- Sep 10, 2025: Damien Lamendola (Chief Executive Officer) bought 896,903 shares, about $950,717. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025092326/0001213900-25-092326-index.htm
- Jul 29, 2025: Damien Lamendola (Chief Executive Officer) bought 371,470 shares, about $401,188. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025070792/0001213900-25-070792-index.htm
- Jul 17, 2025: Damien Lamendola (Chief Executive Officer) bought 86,805 shares, about $99,826. Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025066103/0001213900-25-066103-index.htm

## What management said

- "We believe that these results demonstrate measurable execution on our strategy to build a more resilient, capital-efficient Marpai" Damien Lamendola, Chief Executive Officer (8-K filed Nov 12, 2025). Source: https://www.sec.gov/Archives/edgar/data/1844392/000121390025109369/ea026541001ex99-1_marpai.htm

## Latest filings

- 8-K filed Jul 31, 2026: https://www.sec.gov/Archives/edgar/data/1844392/000121390026084129/ea0300139-8k_marpai.htm
- 10-K filed Mar 25, 2026: https://www.sec.gov/Archives/edgar/data/1844392/000121390026034129/ea0282918-10k_marpai.htm
- 10-Q filed Aug 13, 2026: https://www.sec.gov/Archives/edgar/data/1844392/000121390026089120/ea0300698-10q_marpai.htm
- DEF 14A filed Oct 23, 2026: https://www.sec.gov/Archives/edgar/data/1844392/000121390026112160/ea0309459-def14a_marpai.htm

## About this data

SEC EDGAR filings, read by Steadybase. Every value links to the filing it came from.
Steadybase covers US-headquartered public companies that file with the SEC. API and MCP access: https://steadybase.io/docs/